CBI’s Orphan Drug Innovation Summit 2013
Conference - Philadelphia, PA, United States
CBI is proud to be a partner of the 5th US Rare Disease Day and we are looking to make a difference at our Orphan Drug Innovation Summit this year. In honor of Rare Disease Day, we will be donating a small portion of our proceeds from this year's Summit to benefit a patient organization helping to find a cure for a rare disease.
Over 20 million people in the US are currently afflicted by rare disease. However, since the inception of the Orphan Drug Act in 1983, over 350 drugs have received approval by the FDA to combat these ailments- a significant increase from the 10 passed in the decade before. While this number is impressive, pharmaceutical companies still have a lot of ground to cover. So what is the next step in orphan drug development?
Join us at this interactive summit to:
Anticipate emerging regulatory policies to successfully achieve global market access
Maximize collaboration between pharmaceutical companies, patients, government, and venture capitalists
Explore pricing and reimbursement issues
Capitalize on personalized medicine
(Courtesy of CBI's Orphan Drug Innovation Summit's logo, via orphandruganaut.wordpress.com)
CBI’s Orphan Drug Innovation Summit 2013
Wed, Jul 17, 2013 - Thu, Jul 18, 2013
The Doubletree by Hilton Philadelphia Center City
237 S. Broad Street, Philadelphia, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.